Logo image of CMCM

CHEETAH MOBILE INC - ADR (CMCM) Stock Fundamental Analysis

NYSE:CMCM - US1630752038 - ADR

5.85 USD
-0.16 (-2.66%)
Last: 9/2/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CMCM. CMCM was compared to 280 industry peers in the Software industry. While CMCM seems to be doing ok healthwise, there are quite some concerns on its profitability. CMCM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CMCM had positive earnings in the past year.
In the past year CMCM has reported a negative cash flow from operations.
CMCM had negative earnings in 4 of the past 5 years.
In multiple years CMCM reported negative operating cash flow during the last 5 years.
CMCM Yearly Net Income VS EBIT VS OCF VS FCFCMCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

The Return On Assets of CMCM (-11.37%) is worse than 65.00% of its industry peers.
The Return On Equity of CMCM (-32.94%) is worse than 62.86% of its industry peers.
Industry RankSector Rank
ROA -11.37%
ROE -32.94%
ROIC N/A
ROA(3y)-10.74%
ROA(5y)-6.42%
ROE(3y)-24.89%
ROE(5y)-14.92%
ROIC(3y)N/A
ROIC(5y)N/A
CMCM Yearly ROA, ROE, ROICCMCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

The Gross Margin of CMCM (66.63%) is comparable to the rest of the industry.
CMCM's Gross Margin has been stable in the last couple of years.
CMCM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y0.66%
CMCM Yearly Profit, Operating, Gross MarginsCMCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

CMCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CMCM has more shares outstanding
CMCM has more shares outstanding than it did 5 years ago.
CMCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CMCM Yearly Shares OutstandingCMCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CMCM Yearly Total Debt VS Total AssetsCMCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CMCM has an Altman-Z score of 0.03. This is a bad value and indicates that CMCM is not financially healthy and even has some risk of bankruptcy.
CMCM has a worse Altman-Z score (0.03) than 71.07% of its industry peers.
CMCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.03
ROIC/WACCN/A
WACC9.92%
CMCM Yearly LT Debt VS Equity VS FCFCMCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.23 indicates that CMCM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.23, CMCM is doing worse than 60.36% of the companies in the same industry.
CMCM has a Quick Ratio of 1.23. This is a normal value and indicates that CMCM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.23, CMCM is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
CMCM Yearly Current Assets VS Current LiabilitesCMCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

2

3. Growth

3.1 Past

CMCM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.77%.
Measured over the past years, CMCM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
CMCM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.98%.
CMCM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.06% yearly.
EPS 1Y (TTM)-72.77%
EPS 3Y14.63%
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)-27.98%
Revenue growth 3Y-7.71%
Revenue growth 5Y14.06%
Sales Q2Q%-28.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-78.66%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-59.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CMCM Yearly Revenue VS EstimatesCMCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
CMCM Yearly EPS VS EstimatesCMCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2025 2026 0 10 20 30 40

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.50 indicates a rather cheap valuation of CMCM.
Based on the Price/Earnings ratio, CMCM is valued cheaply inside the industry as 96.07% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CMCM to the average of the S&P500 Index (26.90), we can say CMCM is valued rather cheaply.
The Price/Forward Earnings ratio is 16.46, which indicates a correct valuation of CMCM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMCM indicates a rather cheap valuation: CMCM is cheaper than 83.57% of the companies listed in the same industry.
CMCM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.5
Fwd PE 16.46
CMCM Price Earnings VS Forward Price EarningsCMCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMCM Per share dataCMCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CMCM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHEETAH MOBILE INC - ADR

NYSE:CMCM (9/2/2025, 8:04:00 PM)

5.85

-0.16 (-2.66%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-25 2025-06-25
Earnings (Next)09-08 2025-09-08
Inst Owners3.43%
Inst Owner Change-0.91%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap179.54M
Analysts36.67
Price TargetN/A
Short Float %0.07%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 3.5
Fwd PE 16.46
P/S 1.59
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 1
EV/EBITDA N/A
EPS(TTM)1.67
EY28.55%
EPS(NY)0.36
Fwd EY6.08%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS3.68
BVpS8.67
TBVpS5.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.37%
ROE -32.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.63%
FCFM N/A
ROA(3y)-10.74%
ROA(5y)-6.42%
ROE(3y)-24.89%
ROE(5y)-14.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y0.66%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.36%
Cap/Sales 2.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 0.03
F-Score4
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)28.2%
Cap/Depr(5y)52.64%
Cap/Sales(3y)1.68%
Cap/Sales(5y)2.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.77%
EPS 3Y14.63%
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y-78.66%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.98%
Revenue growth 3Y-7.71%
Revenue growth 5Y14.06%
Sales Q2Q%-28.93%
Revenue Next Year-59.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-148.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-143.29%
OCF growth 3YN/A
OCF growth 5YN/A